Consumers Against High Drug Prices
Exposing The FDA's Regulatory Quagmire
Home
Register
   2015
CoQ10 Wars
   2014
Assembly Line Medicine
Collapsing Within Itself
Intolerable Delays!
"Unsustainable" Cancer Drug Prices
How Government Treated Those For Whom We Now Celebrate Holidays
   2013
Horrific Conditions Inside Drug Factories
When "Rules" Are Broken
Federal Death Panels
Science by Ambush
The Looming Doctor Shortage
   2012
Former FDA Commissioner Admits Risk of Bureaucratic Delay
   2011
FDA Says Walnuts Are Illegal Drugs
The FDA's Most Heinous Drug Approval
No Real Healthcare Cost Crisis
   2010
FDA Delay of One Drug Causes 82,000 Lost Life-Years
Deadly FDA Neglect
How Much More FDA Abuse Can Americans Tolerate?
Drug Company Pleads Guilty to Health Fraud
   2009
Why American Healthcare is Headed for Collapse
The Generic Drug Rip-off
Ending the Atrocities
Millions of Needless Deaths
   2008
Would You Tolerate This Abuse?
The FDA Indicts Itself
The FDA's Cruel Hoax
   2006
Fish Oil Now Available by Prescription!
FDA Threatens to Raid Cherry Orchards
   2005
Inside the FDA's Brain
FDA Fails to Protect Domestic Drug Supply
   2004
FDA Permits New Fish Oil Health Claim
FDA Approves Deadly Drugs, Delays Lifesaving Therapies
The $50.00 Toll Bridge
Dangerous Medicine
Cardiologists Overlook Lifesaving Discovery
What You Don’t Know About Blood Sugar
   2003
Jerry Falwell Attacks Life Extension Foundation
Life Extension Achieves "Impossible" Victory in the U.S. House of Representatives
Fighting the FDA
Patient Advocates Sue FDA Over Drug Access
FDA's Lethal Impediment
Don't Blame the Doctors
One Man's Ten-Year Ordeal With Prostate Cancer
A New Day At FDA?
   2002
The FDA Versus the American Consumer
Supreme Court Roundup
The Lethal Information Gap
Consumer Rape
   2001
Dying From Deficiency
Are Offshore Drugs Dangerous?
Drugs the FDA Says You Can't Have
Does Cholesterol Cause Artery Disease?
What's Wrong with the FDA
FDA Suffers Second Massive Legal Defeat in Pearson v. Shalala
FDA Loses Case Against Compounding Pharmacies on First Amendment Grounds
Ending The Cancer Bureaucracy
   2000
Victory in the House and Senate
Life Extension Wins in the House and Senate
Congress Recognizes The Prescription Drug Problem
Americans are getting Healthier... But the FDA Remains a Major Impediment
Are We to Become Serfs of the Drug Monopoly?
   1999
A Glorious Victory Over FDA Tyranny
The Great American Rip-Off
The Plague Of FDA Regulation
Health Costs to Double Is there a free-market solution?
The FDA versus Folic Acid
   1998
They Want You Brain Dead
Life Extension vs. the FDA a Hollow Victory: Why the Agency's Approval of Ribavirin is Inadequate
 
http://www.fdareview.org/

Drug Company Pleads Guilty to Health Fraud

By William Faloon

Physicians Paid to Illegally Prescribe Drugs

It's one thing to break the law by paying doctors to prescribe drugs that at least have some degree of documented efficacy, but Pfizer went further than this.

Physicians Paid to Illegally Prescribe Drugs

The government's complaint describes how Pfizer created new uses for its patented drugs and then engaged in all kinds of devious schemes to illegally promote these "new uses" to physicians. For instance, Pfizer claimed their drug Lyrica was superior to lower-cost generic medications to treat neuropathic and surgical pain, and then illegally compensated doctors to prescribe Lyrica for these indications.15

Geodon is a drug approved to treat schizophrenia or acute bipolar mania, but the government outlined in its complaint that Pfizer was inappropriately and illegally promoting it for use in children and adults to treat autism, attention deficit hyperactivity disorder, mood disorders, and depression. The government contended that Pfizer illegally promoted Geodon at dosages that were off-label and "offered and paid illegal remuneration to health care professionals to induce them to promote and prescribe Geodon in violation of the Federal Anti-Kickback Statute."16

Zyvox is an antibiotic Pfizer makes to treat deadly antibiotic-resistant MRSA staph infections. The settlement agreement outlined various alleged misconduct relating to the illegal marketing of this drug, including how Pfizer falsely advertised that Zyvox was superior to generic vancomycin and then illegally paid doctors to prescribe it.17

Pfizer Gets By with a Slap on the Wrist

In the settlement agreement, Pfizer only has to agree to admit to the Bextra criminal charge. In exchange for paying a total of $2.3 billion, Pfizer is allowed to claim a denial of the government's other allegations.

Pfizer Gets By with a Slap on the Wrist

To give you an idea what a drop in the bucket this payout is to Pfizer, when a one-time tax break was given to corporations that repatriated offshore profits, Pfizer brought back $37 billion of cash stashed away from its foreign operations.18 Pfizer did this because the tax rate was only 5.25% that year. Considering how much more they made in their largest market (the United States), writing a $2.3 billion check to settle these massive fraud claims is pocket change to a company the size of Pfizer.

This is not the first time Pfizer was caught committing these illegal acts. Prosecutors noted that this was Pfizer's fourth such settlement since 2002.1 In fact, according to the US Attorney, while Pfizer was negotiating deals over past misconduct, they were continuing to violate the same laws with other drugs.19

Contrast Pfizer's "slap-on-the-wrist" fine to what the FDA does to those who practice alternative medicine. Under far less egregious circumstances, the government seizes everything owned by alternative practitioners and often subjects them to harsh jail sentences.

Drug Companies Pay Ghostwriters

According to a study released by editors of the Journal of the American Medical Association, drug companies pay doctors with prestigious university affiliations to put their name on so-called "scientific papers" that are written by ghostwriters.20

These pharmaceutical company-financed articles, carefully calibrated to sell expensive prescription drugs, slip by the peer-review process and make it into the top medical journals. Not only do these articles influence physician prescribing practices, but the media often picks up on them and runs favorable news articles about these deceptively promoted drugs.

As Life Extension reported last year, drug company Wyeth faces 8,400 lawsuits from women who claim Premarin or PremPro caused them to become ill. Court documents from these cases reveal that Wyeth paid ghostwriters to produce 26 "scientific" papers supporting the use of their dangerous female hormone drugs.21

The Wyeth-funded articles extolled purported benefits of these unnatural hormone drugs while downplaying their lethal risks. Nowhere in these articles was Wyeth's role in initiating and paying for them disclosed.

Court documents show how Wyeth contracted with private companies to outline articles, draft them, and then solicit top physicians to sign their names, even though many of the doctors contributed little or no writing to them. These tainted articles were published in medical journals between 1998 and 2005, and helped generate billions of dollars of sales for Wyeth.21

The latest corroboration of large-scale drug company-induced ghostwriting substantiates what Life Extension uncovered decades ago: drug companies manipulate scientific data to deceive doctors into prescribing dangerous drugs.

If you wonder how pharmaceutical companies have been able to defraud the American public for so many decades, look no further than the incestuous relationship they maintain with the FDA. By providing the pharmaceutical industry a virtual monopoly over drug sales in the United States, as the FDA does, consumers have only limited options when they contract a serious illness.

Those who offer alternatives to FDA-approved drugs often find themselves under criminal or civil investigation by any number of federal agencies, thus impeding or outright blocking their ability to compete against pharmaceutical behemoths.

Where to Find Unbiased Drug Information

Not all prescription drugs are fraudulently sold. In fact, some medications confer longevity benefits. The problem is that pharmaceutical companies exert so much control over the FDA that consumers cannot rely on this agency to protect them against dangerous and ineffective drugs.

The Life Extension Foundation is not a patent holder of expensive prescription drugs, nor are we economically beholden to the pharmaceutical industry. Our track record of warning against dangerous drug side effects, while recommending safer and more effective drug uses, exceeds anything that the FDA has ever done to protect consumers.

As a Life Extension member, you obtain unbiased scientific data, free from the scandalous and criminal pharmaceutical company deception most Americans are vulnerable to.

For longer life,

For Longer Life 

William Faloon

References

1. Available at: http://www.miamiherald.com/101/story/1216716.html. Accessed October 21, 2009.

2. Available at: http://www.medicinenet.com/script/main/art.asp?articlekey=46601. Accessed October 21, 2009.

3. Roumie CL, Mitchel EF Jr, Kaltenbach L, Arbogast PG, Gideon P, Griffin MR. Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke. Stroke. 2008 Jul;39(7):2037-45.

4. Roumie CL, Choma NN, Kaltenbach L, Mitchel EF Jr, Arbogast PG, Griffin MR. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease. Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1053-63.

5. Available at: http://online.wsj.com/article/SB125190160702979723.html. Accessed October 21, 2009.

6. Available at: http://www.medscape.com/viewarticle/538008. Accessed October 21, 2009.

7. Khanapure SP, Garvey DS, Janero DR, Letts LG. Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. Curr Top Med Chem. 2007;7(3):311-40.

8. Mao JT, Tsu IH, Dubinett SM, et al. Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide. Clin Cancer Res. 2004 Oct 15;10(20):6872-8.

9. Snyderman CH, Abbas MM, Wagner R, D'Amico F. Inhibition of growth of a murine squamous cell carcinoma by a cyclooxygenase inhibitor increases leukotriene B4 production. Arch Otolaryngol Head Neck Surg. 1995 Sep;121(9):1017-20.

10. Cheng Y, Austin SC, Rocca B, et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science. 2002 Apr 19;296(5567):539-41.

11. Subbarao K, Jala VR, Mathis S, et al. Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms. Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):369-75.

12. Leaberry BA. Aspirin for the prevention of cardiovascular disease: systematic review. J Nurs Care Qual. 2010 Jan-Mar;25(1):17-21.

13. Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol. 2009 Aug 11;54(7):585-94.

14. Srivastava G, Mehta JL. Currying the heart: curcumin and cardioprotection. J Cardiovasc Pharmacol Ther. 2009 Mar;14(1):22-7.

15. Available at: http://www.ahrp.org/cms/content/view/633/9/. Accessed October 28, 2009.

16. Available at: http://www.justice.gov/usao/pae/News/Pr/2009/sep/pfizerrelease.pdf Accessed October 28, 2009.

17. Available at: http://www.reuters.com/article/pressRelease/idUS160827+02-Sep-2009+PRN20090902. Accessed October 28, 2009.

18. Available at: http://www.nytimes.com/2008/06/24/business/24tax.html. Accessed October 28, 2009.

19. Available at: http://www.msnbc.msn.com/id/32657347/ns/business-us_business/. Accessed October 28, 2009.

20. Ross JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA. 2008 Apr 16;299(15):1800-12.

21. Available at: http://www.nytimes.com/2009/08/05/health/research/05ghost.html. Accessed October 29, 2009.

2016 StopFDA.org